Hypophosphatemia in critically ill patients

Satoshi Suzuki, Moritoki Egi, Antoine G. Schneider, Rinaldo Bellomo, Graeme K. Hart, Colin Hegarty

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Purpose: The aim of this study was to assess the association of phosphate concentration with key clinical outcomes in a heterogeneous cohort of critically ill patients. Materials and Methods: This was a retrospective observational study at a general intensive care unit (ICU) of an Australian university teaching hospital enrolling 2730 adult critically ill patients. Results: We studied 10 504 phosphate measurements with a mean value of 1.17 mmol/L (measurements every 28.8 hours on average). Hyperphosphatemia (inorganic phosphate [iP] concentration > 1.4 mmol/L) occurred in 45% and hypophosphatemia (iP ≤ 0.6 mmol/L) in 20%. Among patients without any episodes of hyperphosphatemia, patients with at least 1 episode of hypophosphatemia had a higher ICU mortality than those without hypophosphatemia (P = .004). In addition, ICU nonsurvivors had lower minimum phosphate concentrations than did survivors (P = .009). Similar results were seen for hospital mortality. However, on multivariable logistic regression analysis, hypophosphatemia was not independently associated with ICU mortality (adjusted odds ratio, 0.86 [95% confidence interval, 0.66-1.10]; P = .24) and hospital mortality (odds ratio, 0.89 [0.73-1.07]; P = .21). Even when different cutoff points were used for hypophosphatemia (iP ≤ 0.5, 0.4, 0.3, or 0.2 mmol/L), hypophosphatemia was not an independent risk factor for ICU and hospital morality. In addition, timing of onset and duration of hypophosphatemia were not independent risk factor for ICU and hospital mortality. Conclusions: Hypophosphatemia behaves like a general marker of illness severity and not as an independent predictor of ICU or in-hospital mortality in critically ill patients.

Original languageEnglish
JournalJournal of Critical Care
Volume28
Issue number4
DOIs
Publication statusPublished - Aug 2013
Externally publishedYes

Fingerprint

Hypophosphatemia
Critical Illness
Intensive Care Units
Phosphates
Hospital Mortality
Hyperphosphatemia
Odds Ratio
Mortality
Teaching Hospitals
Observational Studies
Survivors
Retrospective Studies
Logistic Models
Regression Analysis
Confidence Intervals

Keywords

  • Critical illness
  • Hypophosphatemia
  • Inorganic phosphate
  • Intensive care unit
  • Mortality

ASJC Scopus subject areas

  • Critical Care and Intensive Care Medicine

Cite this

Suzuki, S., Egi, M., Schneider, A. G., Bellomo, R., Hart, G. K., & Hegarty, C. (2013). Hypophosphatemia in critically ill patients. Journal of Critical Care, 28(4). https://doi.org/10.1016/j.jcrc.2012.10.011

Hypophosphatemia in critically ill patients. / Suzuki, Satoshi; Egi, Moritoki; Schneider, Antoine G.; Bellomo, Rinaldo; Hart, Graeme K.; Hegarty, Colin.

In: Journal of Critical Care, Vol. 28, No. 4, 08.2013.

Research output: Contribution to journalArticle

Suzuki, S, Egi, M, Schneider, AG, Bellomo, R, Hart, GK & Hegarty, C 2013, 'Hypophosphatemia in critically ill patients', Journal of Critical Care, vol. 28, no. 4. https://doi.org/10.1016/j.jcrc.2012.10.011
Suzuki, Satoshi ; Egi, Moritoki ; Schneider, Antoine G. ; Bellomo, Rinaldo ; Hart, Graeme K. ; Hegarty, Colin. / Hypophosphatemia in critically ill patients. In: Journal of Critical Care. 2013 ; Vol. 28, No. 4.
@article{918d9cb14db6409c985882fc51b8aec1,
title = "Hypophosphatemia in critically ill patients",
abstract = "Purpose: The aim of this study was to assess the association of phosphate concentration with key clinical outcomes in a heterogeneous cohort of critically ill patients. Materials and Methods: This was a retrospective observational study at a general intensive care unit (ICU) of an Australian university teaching hospital enrolling 2730 adult critically ill patients. Results: We studied 10 504 phosphate measurements with a mean value of 1.17 mmol/L (measurements every 28.8 hours on average). Hyperphosphatemia (inorganic phosphate [iP] concentration > 1.4 mmol/L) occurred in 45{\%} and hypophosphatemia (iP ≤ 0.6 mmol/L) in 20{\%}. Among patients without any episodes of hyperphosphatemia, patients with at least 1 episode of hypophosphatemia had a higher ICU mortality than those without hypophosphatemia (P = .004). In addition, ICU nonsurvivors had lower minimum phosphate concentrations than did survivors (P = .009). Similar results were seen for hospital mortality. However, on multivariable logistic regression analysis, hypophosphatemia was not independently associated with ICU mortality (adjusted odds ratio, 0.86 [95{\%} confidence interval, 0.66-1.10]; P = .24) and hospital mortality (odds ratio, 0.89 [0.73-1.07]; P = .21). Even when different cutoff points were used for hypophosphatemia (iP ≤ 0.5, 0.4, 0.3, or 0.2 mmol/L), hypophosphatemia was not an independent risk factor for ICU and hospital morality. In addition, timing of onset and duration of hypophosphatemia were not independent risk factor for ICU and hospital mortality. Conclusions: Hypophosphatemia behaves like a general marker of illness severity and not as an independent predictor of ICU or in-hospital mortality in critically ill patients.",
keywords = "Critical illness, Hypophosphatemia, Inorganic phosphate, Intensive care unit, Mortality",
author = "Satoshi Suzuki and Moritoki Egi and Schneider, {Antoine G.} and Rinaldo Bellomo and Hart, {Graeme K.} and Colin Hegarty",
year = "2013",
month = "8",
doi = "10.1016/j.jcrc.2012.10.011",
language = "English",
volume = "28",
journal = "Journal of Critical Care",
issn = "0883-9441",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Hypophosphatemia in critically ill patients

AU - Suzuki, Satoshi

AU - Egi, Moritoki

AU - Schneider, Antoine G.

AU - Bellomo, Rinaldo

AU - Hart, Graeme K.

AU - Hegarty, Colin

PY - 2013/8

Y1 - 2013/8

N2 - Purpose: The aim of this study was to assess the association of phosphate concentration with key clinical outcomes in a heterogeneous cohort of critically ill patients. Materials and Methods: This was a retrospective observational study at a general intensive care unit (ICU) of an Australian university teaching hospital enrolling 2730 adult critically ill patients. Results: We studied 10 504 phosphate measurements with a mean value of 1.17 mmol/L (measurements every 28.8 hours on average). Hyperphosphatemia (inorganic phosphate [iP] concentration > 1.4 mmol/L) occurred in 45% and hypophosphatemia (iP ≤ 0.6 mmol/L) in 20%. Among patients without any episodes of hyperphosphatemia, patients with at least 1 episode of hypophosphatemia had a higher ICU mortality than those without hypophosphatemia (P = .004). In addition, ICU nonsurvivors had lower minimum phosphate concentrations than did survivors (P = .009). Similar results were seen for hospital mortality. However, on multivariable logistic regression analysis, hypophosphatemia was not independently associated with ICU mortality (adjusted odds ratio, 0.86 [95% confidence interval, 0.66-1.10]; P = .24) and hospital mortality (odds ratio, 0.89 [0.73-1.07]; P = .21). Even when different cutoff points were used for hypophosphatemia (iP ≤ 0.5, 0.4, 0.3, or 0.2 mmol/L), hypophosphatemia was not an independent risk factor for ICU and hospital morality. In addition, timing of onset and duration of hypophosphatemia were not independent risk factor for ICU and hospital mortality. Conclusions: Hypophosphatemia behaves like a general marker of illness severity and not as an independent predictor of ICU or in-hospital mortality in critically ill patients.

AB - Purpose: The aim of this study was to assess the association of phosphate concentration with key clinical outcomes in a heterogeneous cohort of critically ill patients. Materials and Methods: This was a retrospective observational study at a general intensive care unit (ICU) of an Australian university teaching hospital enrolling 2730 adult critically ill patients. Results: We studied 10 504 phosphate measurements with a mean value of 1.17 mmol/L (measurements every 28.8 hours on average). Hyperphosphatemia (inorganic phosphate [iP] concentration > 1.4 mmol/L) occurred in 45% and hypophosphatemia (iP ≤ 0.6 mmol/L) in 20%. Among patients without any episodes of hyperphosphatemia, patients with at least 1 episode of hypophosphatemia had a higher ICU mortality than those without hypophosphatemia (P = .004). In addition, ICU nonsurvivors had lower minimum phosphate concentrations than did survivors (P = .009). Similar results were seen for hospital mortality. However, on multivariable logistic regression analysis, hypophosphatemia was not independently associated with ICU mortality (adjusted odds ratio, 0.86 [95% confidence interval, 0.66-1.10]; P = .24) and hospital mortality (odds ratio, 0.89 [0.73-1.07]; P = .21). Even when different cutoff points were used for hypophosphatemia (iP ≤ 0.5, 0.4, 0.3, or 0.2 mmol/L), hypophosphatemia was not an independent risk factor for ICU and hospital morality. In addition, timing of onset and duration of hypophosphatemia were not independent risk factor for ICU and hospital mortality. Conclusions: Hypophosphatemia behaves like a general marker of illness severity and not as an independent predictor of ICU or in-hospital mortality in critically ill patients.

KW - Critical illness

KW - Hypophosphatemia

KW - Inorganic phosphate

KW - Intensive care unit

KW - Mortality

UR - http://www.scopus.com/inward/record.url?scp=84886704056&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84886704056&partnerID=8YFLogxK

U2 - 10.1016/j.jcrc.2012.10.011

DO - 10.1016/j.jcrc.2012.10.011

M3 - Article

C2 - 23265292

AN - SCOPUS:84886704056

VL - 28

JO - Journal of Critical Care

JF - Journal of Critical Care

SN - 0883-9441

IS - 4

ER -